Paradigm announced today a collaboration with Bristol Myers Squibb to build a new end-to-end clinical trial operating model across design, recruitment, and data collection. Starting with oncology and expanding to other therapeutic areas, Paradigm will enable Bristol Myers Squibb to enroll patients from providers across the Paradigm Network of health systems, all of whom serve diverse groups of patients and already use Paradigm software to reduce the burden of clinical trial recruitment and operations.
privacy policy | terms of use | contact us | advertise | pharma blogs | facebook | twitter
Copyright © 2025,